These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37090586)

  • 1. Defective pgsA contributes to increased membrane fluidity and cell wall thickening in S. aureus with high-level daptomycin resistance.
    Freeman CD; Hansen T; Urbauer R; Wilkinson BJ; Singh VK; Hines KM
    bioRxiv; 2024 Apr; ():. PubMed ID: 37090586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective
    Freeman CD; Hansen T; Urbauer R; Wilkinson BJ; Singh VK; Hines KM
    mSphere; 2024 Jun; 9(6):e0011524. PubMed ID: 38752757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the Mechanisms of Daptomycin Resistance among Gram-Positive Bacterial Pathogens by Multidimensional Lipidomics.
    Hines KM; Waalkes A; Penewit K; Holmes EA; Salipante SJ; Werth BJ; Xu L
    mSphere; 2017; 2(6):. PubMed ID: 29242835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of pyruvate dehydrogenase and branched-chain α-keto acid dehydrogenase in branched-chain membrane fatty acid levels and associated functions in Staphylococcus aureus.
    Singh VK; Sirobhushanam S; Ring RP; Singh S; Gatto C; Wilkinson BJ
    J Med Microbiol; 2018 Apr; 67(4):570-578. PubMed ID: 29498620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of daptomycin resistance in daptomycin-naïve rabbits with methicillin-resistant Staphylococcus aureus prosthetic joint infection is associated with resistance to host defense cationic peptides and mprF polymorphisms.
    Mishra NN; Yang SJ; Chen L; Muller C; Saleh-Mghir A; Kuhn S; Peschel A; Yeaman MR; Nast CC; Kreiswirth BN; Crémieux AC; Bayer AS
    PLoS One; 2013; 8(8):e71151. PubMed ID: 23990934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic and genotypic correlates of daptomycin-resistant methicillin-susceptible Staphylococcus aureus clinical isolates.
    Kang KM; Mishra NN; Park KT; Lee GY; Park YH; Bayer AS; Yang SJ
    J Microbiol; 2017 Feb; 55(2):153-159. PubMed ID: 28120188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gain-of-Function Mutations in the Phospholipid Flippase MprF Confer Specific Daptomycin Resistance.
    Ernst CM; Slavetinsky CJ; Kuhn S; Hauser JN; Nega M; Mishra NN; Gekeler C; Bayer AS; Peschel A
    mBio; 2018 Dec; 9(6):. PubMed ID: 30563904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The phosphatidylglycerol phosphate synthase PgsA utilizes a trifurcated amphipathic cavity for catalysis at the membrane-cytosol interface.
    Yang B; Yao H; Li D; Liu Z
    Curr Res Struct Biol; 2021; 3():312-323. PubMed ID: 34901881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of mprF mutations with cross-resistance to daptomycin and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA).
    Thitiananpakorn K; Aiba Y; Tan XE; Watanabe S; Kiga K; Sato'o Y; Boonsiri T; Li FY; Sasahara T; Taki Y; Azam AH; Zhang Y; Cui L
    Sci Rep; 2020 Sep; 10(1):16107. PubMed ID: 32999359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VraSR two-component regulatory system contributes to mprF-mediated decreased susceptibility to daptomycin in in vivo-selected clinical strains of methicillin-resistant Staphylococcus aureus.
    Mehta S; Cuirolo AX; Plata KB; Riosa S; Silverman JA; Rubio A; Rosato RR; Rosato AE
    Antimicrob Agents Chemother; 2012 Jan; 56(1):92-102. PubMed ID: 21986832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulating activity of vancomycin and daptomycin on the expression of autolysis cell-wall turnover and membrane charge genes in hVISA and VISA strains.
    Cafiso V; Bertuccio T; Spina D; Purrello S; Campanile F; Di Pietro C; Purrello M; Stefani S
    PLoS One; 2012; 7(1):e29573. PubMed ID: 22253738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole genome characterization of the mechanisms of daptomycin resistance in clinical and laboratory derived isolates of Staphylococcus aureus.
    Peleg AY; Miyakis S; Ward DV; Earl AM; Rubio A; Cameron DR; Pillai S; Moellering RC; Eliopoulos GM
    PLoS One; 2012; 7(1):e28316. PubMed ID: 22238576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic and genotypic characterization of daptomycin-resistant methicillin-resistant Staphylococcus aureus strains: relative roles of mprF and dlt operons.
    Mishra NN; Bayer AS; Weidenmaier C; Grau T; Wanner S; Stefani S; Cafiso V; Bertuccio T; Yeaman MR; Nast CC; Yang SJ
    PLoS One; 2014; 9(9):e107426. PubMed ID: 25226591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of cell membrane characteristics of in vitro-selected daptomycin-resistant strains of methicillin-resistant Staphylococcus aureus.
    Mishra NN; Yang SJ; Sawa A; Rubio A; Nast CC; Yeaman MR; Bayer AS
    Antimicrob Agents Chemother; 2009 Jun; 53(6):2312-8. PubMed ID: 19332678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and Distribution of Single-Nucleotide Polymorphisms within mprF in Methicillin-Resistant Staphylococcus aureus Clinical Isolates and Their Role in Cross-Resistance to Daptomycin and Host Defense Antimicrobial Peptides.
    Bayer AS; Mishra NN; Chen L; Kreiswirth BN; Rubio A; Yang SJ
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4930-7. PubMed ID: 26055370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daptomycin resistance in enterococci is associated with distinct alterations of cell membrane phospholipid content.
    Mishra NN; Bayer AS; Tran TT; Shamoo Y; Mileykovskaya E; Dowhan W; Guan Z; Arias CA
    PLoS One; 2012; 7(8):e43958. PubMed ID: 22952824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of compensatory mutations associated with restoration of daptomycin-susceptibility in daptomycin non-susceptible methicillin-resistant Staphylococcus aureus and the role mprF mutations.
    Kanesaka I; Fujisaki S; Aiba Y; Watanabe S; Mikawa T; Katsuse AK; Takahashi H; Cui L; Kobayashi I
    J Infect Chemother; 2019 Jan; 25(1):1-5. PubMed ID: 30322736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo development of daptomycin resistance in vancomycin-susceptible methicillin-resistant Staphylococcus aureus severe infections previously treated with glycopeptides.
    Capone A; Cafiso V; Campanile F; Parisi G; Mariani B; Petrosillo N; Stefani S
    Eur J Clin Microbiol Infect Dis; 2016 Apr; 35(4):625-31. PubMed ID: 26815434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased cell wall teichoic acid production and D-alanylation are common phenotypes among daptomycin-resistant methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates.
    Bertsche U; Yang SJ; Kuehner D; Wanner S; Mishra NN; Roth T; Nega M; Schneider A; Mayer C; Grau T; Bayer AS; Weidenmaier C
    PLoS One; 2013; 8(6):e67398. PubMed ID: 23785522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell Membrane Adaptations Mediate β-Lactam-Induced Resensitization of Daptomycin-Resistant (DAP-R)
    Mishra NN; Bayer AS; Baines SL; Hayes AS; Howden BP; Lapitan CK; Lew C; Rose WE
    Microorganisms; 2021 May; 9(5):. PubMed ID: 34064631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.